NewsBenzinga월마트, 약국 부문 디플레이션 역풍에도 불구 애널리스트 평가 월마트, 약국 부문 디플레이션 역풍에도 불구 애널리스트 평가 Benzinga 2026.11.20 18:19 (GMT+0) Open on Benzinga Other news UBS Maintains Buy on Keysight Techs, Lowers Price Target to $380 UBS Maintains Neutral on Intuit, Lowers Price Target to $315 Walmart Gets Bullish Rating Despite Pharmacy Deflation Headwinds Sky's USDC Exit Reserve Rises 29% to 1.13 Billion UBS Maintains Neutral on Ingredion, Lowers Price Target to $98 UBS Maintains Neutral on Hewlett Packard, Lowers Price Target to $52